In which patient population is bempedoic acid particularly used?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

In which patient population is bempedoic acid particularly used?

Bempedoic acid is used as an add-on LDL-C–lowering therapy for patients who cannot tolerate statins or who need additional LDL-C reduction beyond what statins alone achieve. Mechanistically, it inhibits ATP citrate lyase in the liver, reducing hepatic cholesterol synthesis and increasing LDL receptor activity, which lowers circulating LDL-C. Because it acts mainly in the liver, it has a lower risk of muscle-related side effects, making it a practical option for statin-intolerant individuals. Clinically, this means adults with ASCVD or heterozygous familial hypercholesterolemia who require further LDL-C lowering despite maximally tolerated statin therapy can benefit. It’s not first-line for everyone, and its role isn’t limited to triglyceride lowering or to use only after PCSK9 inhibitors fail. The typical additional LDL-C reduction when added to statin therapy is about 15–20%.

Bempedoic acid is used as an add-on LDL-C–lowering therapy for patients who cannot tolerate statins or who need additional LDL-C reduction beyond what statins alone achieve. Mechanistically, it inhibits ATP citrate lyase in the liver, reducing hepatic cholesterol synthesis and increasing LDL receptor activity, which lowers circulating LDL-C. Because it acts mainly in the liver, it has a lower risk of muscle-related side effects, making it a practical option for statin-intolerant individuals. Clinically, this means adults with ASCVD or heterozygous familial hypercholesterolemia who require further LDL-C lowering despite maximally tolerated statin therapy can benefit. It’s not first-line for everyone, and its role isn’t limited to triglyceride lowering or to use only after PCSK9 inhibitors fail. The typical additional LDL-C reduction when added to statin therapy is about 15–20%.

More practice questions